Inflammation during fetal and neonatal life: Implications for neurologic and neuropsychiatric disease in children and adults

Annals of Neurology

Volumn 71, Issue 4, 2012, Pages 444-457

  Hagberg, Henrik ^a,b   Gressens, Pierre ^b,c,d,e   Mallard, Carina ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c INSERM   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e PremUP   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CD14 ANTIGEN; CD40 ANTIGEN; CD45 ANTIGEN; CD86 ANTIGEN; CELL THERAPY AGENT; GLUTAMATE RECEPTOR; GLYCOPROTEIN P 15095; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MICRORNA; MICRORNA 146A; MICRORNA 155; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2C; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 8; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ASTROCYTE; AUTISM; BLOOD BRAIN BARRIER; BRAIN DEVELOPMENT; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM; CHORIOAMNIONITIS; CHOROID PLEXUS; DENDRITIC CELL; DISEASE ASSOCIATION; DNA METHYLATION; EPIGENETICS; EXCITOTOXICITY; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INFLUENZA; INNATE IMMUNITY; INTRACELLULAR SIGNALING; MACROPHAGE; MICROGLIA; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OLIGODENDROGLIA; OXIDATIVE STRESS; PARKINSON DISEASE; PHAGOCYTOSIS; PREMATURE LABOR; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SEIZURE SUSCEPTIBILITY; TH1 CELL; TH17 CELL; TH2 CELL;

ADULT; BRAIN; FEMALE; FETUS; HUMANS; INFANT, NEWBORN; INFLAMMATION; MENTAL DISORDERS; NERVOUS SYSTEM DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 84860222551     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22620     Document Type: Review

References (180)

1. Hagberg H, Mallard C,. Effect of inflammation on central nervous system development and vulnerability. Curr Opin Neurol 2005; 18: 117-123.
2. Vexler ZS, Yenari MA,. Does inflammation after stroke affect the developing brain differently than adult brain? Dev Neurosci 2009; 31: 378-393.
3. Degos V, Favrais G, Kaindl AM, et al. Inflammation processes in perinatal brain damage. J Neural Transm 2010; 117: 1009-1017.
4. Galea I, Bechmann I, Perry VH,. What is immune privilege (not)? Trends Immunol 2007; 28: 12-18.
5. Bechmann I, Galea I, Perry VH,. What is the blood-brain barrier (not)? Trends Immunol 2007; 28: 5-11.
6. Bianchi ME,. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007; 81: 1-5.
7. Farina C, Aloisi F, Meinl E,. Astrocytes are active players in cerebral innate immunity. Trends Immunol 2007; 28: 138-145.
8. Santambrogio L, Belyanskaya SL, Fischer FR, et al. Developmental plasticity of CNS microglia. Proc Natl Acad Sci U S A 2001; 98: 6295-6300.
9. Ransohoff RM, Perry VH,. Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 2009; 27: 119-145.
10. Ginhoux F, Greter M, Leboeuf M, et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010; 330: 841-845.
11. Nimmerjahn A, Kirchhoff F, Helmchen F,. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005; 308: 1314-1318.
12. Perry VH, Nicoll JA, Holmes C,. Microglia in neurodegenerative disease. Nat Rev Neurol 2010; 6: 193-201.
13. Hickey WF, Kimura H,. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 1988; 239: 290-292.
14. Kida S, Steart PV, Zhang ET, Weller RO,. Perivascular cells act as scavengers in the cerebral perivascular spaces and remain distinct from pericytes, microglia and macrophages. Acta Neuropathol 1993; 85: 646-652.
15. Galea I, Palin K, Newman TA, et al. Mannose receptor expression specifically reveals perivascular macrophages in normal, injured, and diseased mouse brain. Glia 2005; 49: 375-384.
16. Fabriek BO, Van Haastert ES, Galea I, et al. CD163-positive perivascular macrophages in the human CNS express molecules for antigen recognition and presentation. Glia 2005; 51: 297-305.
17. Greter M, Heppner FL, Lemos MP, et al. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat Med 2005; 11: 328-334.
18. Mills CD, Kincaid K, Alt JM, et al. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 2000; 164: 6166-6173.
19. Kigerl KA, Gensel JC, Ankeny DP, et al. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 2009; 29: 13435-13444.
20. Colton CA,. Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol 2009; 4: 399-418.
21. Colton CA, Mott RT, Sharpe H, et al. Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J Neuroinflammation 2006; 3: 27.
22. Mikita J, Dubourdieu-Cassagno N, Deloire MS, et al. Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Mult Scler 2011; 17: 2-15.
23. Soulet D, Rivest S,. Bone-marrow-derived microglia: myth or reality? Curr Opin Pharmacol 2008; 8: 508-518.
24. Yong VW, Marks S,. The interplay between the immune and central nervous systems in neuronal injury. Neurology 2010; 74 (suppl 1): S9-S16.
25. Bona E, Andersson AL, Blomgren K, et al. Chemokine and inflammatory cell response to hypoxia-ischemia in immature rats. Pediatr Res 1999; 45: 500-509.
26. Schwartz M, Cohen I, Lazarov-Spiegler O, et al. The remedy may lie in ourselves: prospects for immune cell therapy in central nervous system protection and repair. J Mol Med 1999; 77: 713-717.
27. Ziv Y, Ron N, Butovsky O, et al. Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat Neurosci 2006; 9: 268-275.
28. Hendrix S, Nitsch R,. The role of T helper cells in neuroprotection and regeneration. J Neuroimmunol 2007; 184: 100-112.
29. Laflamme N, Rivest S,. Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components. FASEB J 2001; 15: 155-163.
30. Bsibsi M, Ravid R, Gveric D, van Noort JM,. Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 2002; 61: 1013-1021.
31. Jack CS, Arbour N, Manusow J, et al. TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol 2005; 175: 4320-4330.
32. Farina C, Krumbholz M, Giese T, et al. Preferential expression and function of Toll-like receptor 3 in human astrocytes. J Neuroimmunol 2005; 159: 12-19.
33. Tang SC, Arumugam TV, Xu X, et al. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc Natl Acad Sci U S A 2007; 104: 13798-13803.
34. Mishra BB, Mishra PK, Teale JM,. Expression and distribution of Toll-like receptors in the brain during murine neurocysticercosis. J Neuroimmunol 2006; 181: 46-56.
35. Eklind S, Mallard C, Leverin AL, et al. Bacterial endotoxin sensitizes the immature brain to hypoxic-ischaemic injury. Eur J Neurosci 2001; 13: 1101-1106.
36. Lathia JD, Okun E, Tang SC, et al. Toll-like receptor 3 is a negative regulator of embryonic neural progenitor cell proliferation. J Neurosci 2008; 28: 13978-13984.
37. Okun E, Griffioen KJ, Son TG, et al. TLR2 activation inhibits embryonic neural progenitor cell proliferation. J Neurochem 2010; 114: 462-474.
38. Ma Y, Haynes RL, Sidman RL, Vartanian T,. TLR8: an innate immune receptor in brain, neurons and axons. Cell Cycle 2007; 6: 2859-2868.
39. Cameron JS, Alexopoulou L, Sloane JA, et al. Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals. J Neurosci 2007; 27: 13033-13041.
40. Rolls A, Shechter R, London A, et al. Toll-like receptors modulate adult hippocampal neurogenesis. Nat Cell Biol 2007; 9: 1081-1088.
41. Covacu R, Arvidsson L, Andersson A, et al. TLR activation induces TNF-alpha production from adult neural stem/progenitor cells. J Immunol 2009; 182: 6889-6895.
42. Blanchard F, Chipoy C,. Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases? Drug Discov Today 2005; 10: 197-204.
43. Abel T, Zukin RS,. Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr Opin Pharmacol 2008; 8: 57-64.
44. Kim HJ, Leeds P, Chuang DM,. The HDAC inhibitor, sodium butyrate, stimulates neurogenesis in the ischemic brain. J Neurochem 2009; 110: 1226-1240.
45. Prozorovski T, Schulze-Topphoff U, Glumm R, et al. Sirt1 contributes critically to the redox-dependent fate of neural progenitors. Nat Cell Biol 2008; 10: 385-394.
46. Faraco G, Pittelli M, Cavone L, et al. Histone deacetylase (HDAC) inhibitors reduce the glial inflammatory response in vitro and in vivo. Neurobiol Dis 2009; 36: 269-279.
47. Kim HJ, Rowe M, Ren M, et al. Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J Pharmacol Exp Ther 2007; 321: 892-901.
48. Fowden AL, Sibley C, Reik W, Constancia M,. Imprinted genes, placental development and fetal growth. Horm Res 2006; 65 (suppl 3): 50-58.
49. Shuto T, Furuta T, Oba M, et al. Promoter hypomethylation of Toll-like receptor-2 gene is associated with increased proinflammatory response toward bacterial peptidoglycan in cystic fibrosis bronchial epithelial cells. FASEB J 2006; 20: 782-784.
50. Taganov KD, Boldin MP, Chang KJ, Baltimore D,. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 2006; 103: 12481-12486.
51. O'Connell RM, Taganov KD, Boldin MP, et al. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 2007; 104: 1604-1609.
52. Dommergues MA, Plaisant F, Verney C, Gressens P,. Early microglial activation following neonatal excitotoxic brain damage in mice: a potential target for neuroprotection. Neuroscience 2003; 121: 619-628.
53. Derugin N, Wendland M, Muramatsu K, et al. Evolution of brain injury after transient middle cerebral artery occlusion in neonatal rats. Stroke 2000; 31: 1752-1761.
54. McRae A, Gilland E, Bona E, Hagberg H,. Microglia activation after neonatal hypoxic-ischemia. Brain Res Dev Brain Res 1995; 84: 245-252.
55. Tahraoui SL, Marret S, Bodenant C, et al. Central role of microglia in neonatal excitotoxic lesions of the murine periventricular white matter. Brain Pathol 2001; 11: 56-71.
56. Hudome S, Palmer C, Roberts RL, et al. The role of neutrophils in the production of hypoxic-ischemic brain injury in the neonatal rat. Pediatr Res 1997; 41: 607-616.
57. Patkai J, Mesples B, Dommergues MA, et al. Deleterious effects of IL-9-activated mast cells and neuroprotection by antihistamine drugs in the developing mouse brain. Pediatr Res 2001; 50: 222-230.
58. Jin Y, Silverman AJ, Vannucci SJ,. Mast cells are early responders after hypoxia-ischemia in immature rat brain. Stroke 2009; 40: 3107-3112.
59. Hagberg H, Gilland E, Bona E, et al. Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats. Pediatr Res 1996; 40: 603-609.
60. Ivacko J, Szaflarski J, Malinak C, et al. Hypoxic-ischemic injury induces monocyte chemoattractant protein-1 expression in neonatal rat brain. J Cereb Blood Flow Metab 1997; 17: 759-770.
61. Silverstein FS, Barks JD, Hagan P, et al. Cytokines and perinatal brain injury. Neurochem Int 1997; 30: 375-383.
62. Hedtjarn M, Leverin AL, Eriksson K, et al. Interleukin-18 involvement in hypoxic-ischemic brain injury. J Neurosci 2002; 22: 5910-5919.
63. Hedtjarn M, Mallard C, Hagberg H,. Inflammatory gene profiling in the developing mouse brain after hypoxia-ischemia. J Cereb Blood Flow Metab 2004; 24: 1333-1351.
64. Kim SU, de Vellis J,. Microglia in health and disease. J Neurosci Res 2005; 81: 302-313.
65. Giulian D, Vaca K,. Inflammatory glia mediate delayed neuronal damage after ischemia in the central nervous system. Stroke 1993; 24 (suppl 12): I84-I90.
66. Liu XH, Eun BL, Silverstein FS, Barks JD,. The platelet-activating factor antagonist BN 52021 attenuates hypoxic-ischemic brain injury in the immature rat. Pediatr Res 1996; 40: 797-803.
67. Liu XH, Kwon D, Schielke GP, et al. Mice deficient in interleukin-1 converting enzyme are resistant to neonatal hypoxic-ischemic brain damage. J Cereb Blood Flow Metab 1999; 19: 1099-1108.
68. Ten VS, Sosunov SA, Mazer SP, et al. C1q-deficiency is neuroprotective against hypoxic-ischemic brain injury in neonatal mice. Stroke 2005; 36: 2244-2250.
69. Dommergues MA, Patkai J, Renauld JC, et al. Proinflammatory cytokines and interleukin-9 exacerbate excitotoxic lesions of the newborn murine neopallium. Ann Neurol 2000; 47: 54-63.
70. Mesples B, Plaisant F, Gressens P,. Effects of interleukin-10 on neonatal excitotoxic brain lesions in mice. Brain Res Dev Brain Res 2003; 141: 25-32.
71. Imai F, Suzuki H, Oda J, et al. Neuroprotective effect of exogenous microglia in global brain ischemia. J Cereb Blood Flow Metab 2007; 27: 488-500.
72. Pekny M, Wilhelmsson U, Bogestal YR, Pekna M,. The role of astrocytes and complement system in neural plasticity. Int Rev Neurobiol 2007; 82: 95-111.
73. Denker SP, Ji S, Dingman A, et al. Macrophages are comprised of resident brain microglia not infiltrating peripheral monocytes acutely after neonatal stroke. J Neurochem 2007; 100: 893-904.
74. Saunders NR, Habgood MD, Dziegielewska KM,. Barrier mechanisms in the brain, II. Immature brain. Clin Exp Pharmacol Physiol 1999; 26: 85-91.
75. Goldenberg RL, Culhane JF, Iams JD, Romero R,. Epidemiology and causes of preterm birth. Lancet 2008; 371: 75-84.
76. Romero R, Gotsch F, Pineles B, Kusanovic JP,. Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury. Nutr Rev 2007; 65: 194-202.
77. Leviton A,. Preterm birth and cerebral palsy: is tumor necrosis factor the missing link? Dev Med Child Neurol 1993; 35: 553-558.
78. Dammann O, Leviton A,. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 1997; 42: 1-8.
79. Dammann O, Leviton A,. Role of the fetus in perinatal infection and neonatal brain damage. Curr Opin Pediatr 2000; 12: 99-104.
80. Verma U, Tejani N, Klein S, et al. Obstetric antecedents of intraventricular hemorrhage and periventricular leukomalacia in the low-birth-weight neonate. Am J Obstet Gynecol 1997; 176: 275-281.
81. Dammann O, Allred EN, Veelken N,. Increased risk of spastic diplegia among very low birth weight children after preterm labor or prelabor rupture of membranes. J Pediatr 1998; 132: 531-535.
82. Jacobsson B, Hagberg G, Hagberg B, et al. Cerebral palsy in preterm infants: a population-based case-control study of antenatal and intrapartal risk factors. Acta Paediatr 2002; 91: 946-951.
83. Leviton A, Paneth N, Reuss ML, et al. Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants. Developmental Epidemiology Network Investigators. Pediatr Res 1999; 46: 566-575.
84. Redline RW, O'Riordan MA,. Placental lesions associated with cerebral palsy and neurologic impairment following term birth. Arch Pathol Lab Med 2000; 124: 1785-1791.
85. Yoon BH, Romero R, Yang SH, et al. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 1996; 174: 1433-1440.
86. Yoon BH, Jun JK, Romero R, et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997; 177: 19-26.
87. Yoon BH, Romero R, Park JS, et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000; 182: 675-681.
88. Wu YW, Colford JM Jr,. Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA 2000; 284: 1417-1424.
89. Wu YW,. Systematic review of chorioamnionitis and cerebral palsy. Ment Retard Dev Disabil Res Rev 2002; 8: 25-29.
90. Resch B, Radinger A, Mannhalter C, et al. Interleukin-6 G( - 174)C polymorphism is associated with mental retardation in cystic periventricular leucomalacia in preterm infants. Arch Dis Child Fetal Neonatal Ed 2009; 94: 304-306.
91. Gilles FH, Averill DR Jr, Kerr CS,. Neonatal endotoxin encephalopathy. Ann Neurol 1977; 2: 49-56.
92. Young RS, Yagel SK, Towfighi J,. Systemic and neuropathologic effects of E. coli endotoxin in neonatal dogs. Pediatr Res 1983; 17: 349-353.
93. Duncan JR, Cock ML, Scheerlinck JP, et al. White matter injury after repeated endotoxin exposure in the preterm ovine fetus. Pediatr Res 2002; 52: 941-949.
94. Mallard C, Welin AK, Peebles D, et al. White matter injury following systemic endotoxemia or asphyxia in the fetal sheep. Neurochem Res 2003; 28: 215-223.
95. Hagberg H, Peebles D, Mallard C,. Models of white matter injury: comparison of infectious, hypoxic-ischemic, and excitotoxic insults. Ment Retard Dev Disabil Res Rev 2002; 8: 30-38.
96. Duncan JR, Cock ML, Suzuki K, et al. Chronic endotoxin exposure causes brain injury in the ovine fetus in the absence of hypoxemia. J Soc Gynecol Investig 2006; 13: 87-96.
97. Dalitz P, Harding R, Rees SM, Cock ML,. Prolonged reductions in placental blood flow and cerebral oxygen delivery in preterm fetal sheep exposed to endotoxin: possible factors in white matter injury after acute infection. J Soc Gynecol Investig 2003; 10: 283-290.
98. Nelson KB, Grether JK, Dambrosia JM, et al. Neonatal cytokines and cerebral palsy in very preterm infants. Pediatr Res 2003; 53: 600-607.
99. Kaukola T, Herva R, Perhomaa M, et al. Population cohort associating chorioamnionitis, cord inflammatory cytokines and neurologic outcome in very preterm, extremely low birth weight infants. Pediatr Res 2006; 59: 478-483.
100. Reiman M, Kujari H, Maunu J, et al. Does placental inflammation relate to brain lesions and volume in preterm infants? J Pediatr 2008; 152: 642-647.
101. Kumazaki K, Nakayama M, Sumida Y, et al. Placental features in preterm infants with periventricular leukomalacia. Pediatrics 2002; 109: 650-655.
102. Chau V, Poskitt KJ, McFadden DE, et al. Effect of chorioamnionitis on brain development and injury in premature newborns. Ann Neurol 2009; 66: 155-164.
103. Nelson KB, Willoughby RE,. Infection, inflammation and the risk of cerebral palsy. Curr Opin Neurol 2000; 13: 133-139.
104. Lee SY, Ng DK, Fung GP, et al. Chorioamnionitis with or without funisitis increases the risk of hypotension in very low birthweight infants on the first postnatal day but not later. Arch Dis Child Fetal Neonatal Ed 2006; 91: 346-348.
105. Eklind S, Arvidsson P, Hagberg H, Mallard C,. The role of glucose in brain injury following the combination of lipopolysaccharide or lipoteichoic acid and hypoxia-ischemia in neonatal rats. Dev Neurosci 2004; 26: 61-67.
106. Eklind S, Mallard C, Arvidsson P, Hagberg H,. Lipopolysaccharide induces both a primary and a secondary phase of sensitization in the developing rat brain. Pediatr Res 2005; 58: 112-116.
107. Lehnardt S, Massillon L, Follett P, et al. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci U S A 2003; 100: 8514-8519.
108. Wang X, Stridh L, Li W, et al. Lipopolysaccharide sensitizes neonatal hypoxic-ischemic brain injury in a MyD88-dependent manner. J Immunol 2009; 183: 7471-7477.
109. Aden U, Favrais G, Plaisant F, et al. Systemic inflammation sensitizes the neonatal brain to excitotoxicity through a pro-/anti-inflammatory imbalance: key role of TNFalpha pathway and protection by etanercept. Brain Behav Immun 2010; 24: 747-758.
110. Favrais G, Schwendimann L, Gressens P, Lelievre V,. Cyclooxygenase-2 mediates the sensitizing effects of systemic IL-1-beta on excitotoxic brain lesions in newborn mice. Neurobiol Dis 2007; 25: 496-505.
111. Larouche A, Roy M, Kadhim H, et al. Neuronal injuries induced by perinatal hypoxic-ischemic insults are potentiated by prenatal exposure to lipopolysaccharide: animal model for perinatally acquired encephalopathy. Dev Neurosci 2005; 27: 134-142.
112. Spencer SJ, Auer RN, Pittman QJ,. Rat neonatal immune challenge alters adult responses to cerebral ischaemia. J Cereb Blood Flow Metab 2006; 26: 456-467.
113. Wang X, Hagberg H, Nie C, et al. Dual role of intrauterine immune challenge on neonatal and adult brain vulnerability to hypoxia-ischemia. J Neuropathol Exp Neurol 2007; 66: 552-561.
114. Craft TK, Zhang N, Glasper ER, et al. Neonatal factors influence adult stroke outcome. Psychoneuroendocrinology 2006; 31: 601-613.
115. Fombonne E,. Epidemiology of pervasive developmental disorders. Pediatr Res 2009; 65: 591-598.
116. Desmond MM, Montgomery JR, Melnick JL, et al. Congenital rubella encephalitis. Effects on growth and early development. Am J Dis Child 1969; 118: 30-31.
117. Atladottir HO, Thorsen P, Ostergaard L, et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord 2010; 40: 1423-1430.
118. Marlow N, Wolke D, Bracewell MA, Samara M,. Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med 2005; 352: 9-19.
119. Johnson S, Hollis C, Kochhar P, et al. Autism spectrum disorders in extremely preterm children. J Pediatr 2010; 156: 525-531.
120. Malik M, Sheikh AM, Wen G, et al. Expression of inflammatory cytokines, Bcl2 and cathepsin D are altered in lymphoblasts of autistic subjects. Immunobiology 2011; 216: 80-85.
121. Jyonouchi H, Sun S, Le H,. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol 2001; 120: 170-179.
122. Vargas DL, Nascimbene C, Krishnan C, et al. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005; 57: 67-81.
123. Jyonouchi H, Geng L, Ruby A, Zimmerman-Bier B,. Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiology 2005; 51: 77-85.
124. Meyer U, Nyffeler M, Engler A, et al. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci 2006; 26: 4752-4762.
125. Heijtz RD, Wang S, Anuar F, et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A 2011; 108: 3047-3052.
126. Moy SS, Nadler JJ,. Advances in behavioral genetics: mouse models of autism. Mol Psychiatry 2008; 13: 4-26.
127. Tamminga CA, Holcomb HH,. Phenotype of schizophrenia: a review and formulation. Mol Psychiatry 2005; 10: 27-39.
128. Fatemi SH, Folsom TD,. The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr Bull 2009; 35: 528-548.
129. Argyropoulos SV, Landau S, Kalidindi S, et al. Twins discordant for schizophrenia: psychopathology of the non-schizophrenic co-twins. Acta Psychiatr Scand 2008; 118: 214-219.
130. Mednick SA, Machon RA, Huttunen MO, Bonett D,. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry 1988; 45: 189-192.
131. Boksa P,. Maternal infection during pregnancy and schizophrenia. J Psychiatry Neurosci 2008; 33: 183-185.
132. Brown AS, Vinogradov S, Kremen WS, et al. Prenatal exposure to maternal infection and executive dysfunction in adult schizophrenia. Am J Psychiatry 2009; 166: 683-690.
133. Meyer U, Feldon J,. Neural basis of psychosis-related behaviour in the infection model of schizophrenia. Behav Brain Res 2009; 204: 322-334.
134. Brown AS, Cohen P, Harkavy-Friedman J, et al. A.E. Bennett Research Award. Prenatal rubella, premorbid abnormalities, and adult schizophrenia. Biol Psychiatry 2001; 49: 473-486.
135. Brown AS, Begg MD, Gravenstein S, et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 2004; 61: 774-780.
136. Buka SL, Tsuang MT, Torrey EF, et al. Maternal cytokine levels during pregnancy and adult psychosis. Brain Behav Immun 2001; 15: 411-420.
137. Brown AS, Hooton J, Schaefer CA, et al. Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry 2004; 161: 889-895.
138. Meyer U, Feldon J, Schedlowski M, Yee BK,. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev 2005; 29: 913-947.
139. Shi L, Fatemi SH, Sidwell RW, Patterson PH,. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 2003; 23: 297-302.
140. Meyer U, Feldon J, Schedlowski M, Yee BK,. Immunological stress at the maternal-foetal interface: a link between neurodevelopment and adult psychopathology. Brain Behav Immun 2006; 20: 378-388.
141. Fortier ME, Joober R, Luheshi GN, Boksa P,. Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring. J Psychiatr Res 2004; 38: 335-345.
142. Fortier ME, Luheshi GN, Boksa P,. Effects of prenatal infection on prepulse inhibition in the rat depend on the nature of the infectious agent and the stage of pregnancy. Behav Brain Res 2007; 181: 270-277.
143. Samuelsson AM, Alexanderson C, Molne J, et al. Prenatal exposure to interleukin-6 results in hypertension and alterations in the renin-angiotensin system of the rat. J Physiol 2006; 575: 855-867.
144. Smith SE, Li J, Garbett K, et al. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 2007; 27: 10695-10702.
145. Meyer U, Murray PJ, Urwyler A, et al. Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling. Mol Psychiatry 2008; 13: 208-221.
146. Murray RM, O'Callaghan E, Castle DJ, Lewis SW,. A neurodevelopmental approach to the classification of schizophrenia. Schizophr Bull 1992; 18: 319-332.
147. Vuillermot S, Weber L, Feldon J, Meyer U,. A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia. J Neurosci 2010; 30: 1270-1287.
148. Hashimoto T, Volk DW, Eggan SM, et al. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci 2003; 23: 6315-6326.
149. Nyffeler M, Meyer U, Yee BK, et al. Maternal immune activation during pregnancy increases limbic GABAA receptor immunoreactivity in the adult offspring: implications for schizophrenia. Neuroscience 2006; 143: 51-62.
150. Ni L, Acevedo G, Muralidharan B, et al. Toll-like receptor ligands and CD154 stimulate microglia to produce a factor(s) that promotes excess cholinergic differentiation in the developing rat basal forebrain: implications for neurodevelopmental disorders. Pediatr Res 2007; 61: 15-20.
151. Meyer U, Nyffeler M, Yee BK, et al. Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice. Brain Behav Immun 2008; 22: 469-486.
152. Bitanihirwe BK, Weber L, Feldon J, Meyer U,. Cognitive impairment following prenatal immune challenge in mice correlates with prefrontal cortical AKT1 deficiency. Int J Neuropsychopharmacol 2010; 13: 981-996.
153. Bitanihirwe BK, Peleg-Raibstein D, Mouttet F, et al. Late prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophrenia. Neuropsychopharmacology 2010; 35; 2462-2478.
154. Fatemi SH, Emamian ES, Kist D, et al. Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice. Mol Psychiatry 1999; 4: 145-154.
155. Fatemi SH, Earle J, Kanodia R, et al. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell Mol Neurobiol 2002; 22: 25-33.
156. Zuckerman L, Rehavi M, Nachman R, Weiner I,. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology 2003; 28: 1778-1789.
157. Makinodan M, Tatsumi K, Manabe T, et al. Maternal immune activation in mice delays myelination and axonal development in the hippocampus of the offspring. J Neurosci Res 2008; 86: 2190-2200.
158. Gardener H, Gao X, Chen H, et al. Prenatal and early life factors and risk of Parkinson's disease. Mov Disord 2010; 25: 1560-1567.
159. Borenstein AR, Wu Y, Mortimer JA, et al. Developmental and vascular risk factors for Alzheimer's disease. Neurobiol Aging 2005; 26: 325-334.
160. Ling Z, Gayle DA, Ma SY, et al. In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain. Mov Disord 2002; 17: 116-124.
161. Carvey PM, Chang Q, Lipton JW, Ling Z,. Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: a potential, new model of Parkinson's disease. Front Biosci 2003; 8: 826-837.
162. Fan LW, Tien LT, Zheng B, et al. Dopaminergic neuronal injury in the adult rat brain following neonatal exposure to lipopolysaccharide and the silent neurotoxicity. Brain Behav Immun 2011; 25: 286-297.
163. Chen GH, Wang H, Yang QG, et al. Acceleration of age-related learning and memory decline in middle-aged CD-1 mice due to maternal exposure to lipopolysaccharide during late pregnancy. Behav Brain Res 2011; 218: 267-279.
164. Golan H, Stilman M, Lev V, Huleihel M,. Normal aging of offspring mice of mothers with induced inflammation during pregnancy. Neuroscience 2006; 141: 1909-1918.
165. Dammann O, Hagberg H, Leviton A,. Is periventricular leukomalacia an axonopathy as well as an oligopathy? Pediatr Res 2001; 49: 453-457.
166. Ebers GC, Sadovnick AD, Dyment DA, et al. Parent-of-origin effect in multiple sclerosis: observations in half-siblings. Lancet 2004; 363: 1773-1774.
167. Hoppenbrouwers IA, Liu F, Aulchenko YS, et al. Maternal transmission of multiple sclerosis in a Dutch population. Arch Neurol 2008; 65: 345-348.
168. Harre EM, Galic MA, Mouihate A, et al. Neonatal inflammation produces selective behavioural deficits and alters N-methyl-D-aspartate receptor subunit mRNA in the adult rat brain. Eur J Neurosci 2008; 27: 644-653.
169. Galic MA, Riazi K, Henderson AK, et al. Viral-like brain inflammation during development causes increased seizure susceptibility in adult rats. Neurobiol Dis 2009; 36: 343-351.
170. Galic MA, Riazi K, Heida JG, et al. Postnatal inflammation increases seizure susceptibility in adult rats. J Neurosci 2008; 28: 6904-6913.
171. Svedin P, Hagberg H, Savman K, et al. Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia. J Neurosci 2007; 27: 1511-1518.
172. Kadhim H, Tabarki B, De Prez C, et al. Interleukin-2 in the pathogenesis of perinatal white matter damage. Neurology 2002; 58: 1125-1128.
173. Bartha AI, Foster-Barber A, Miller SP, et al. Neonatal encephalopathy: association of cytokines with MR spectroscopy and outcome. Pediatr Res 2004; 56: 960-966.
174. Cowell RM, Xu H, Galasso JM, Silverstein FS,. Hypoxic-ischemic injury induces macrophage inflammatory protein-1alpha expression in immature rat brain. Stroke 2002; 33: 795-801.
175. Graham EM, Sheldon RA, Flock DL, et al. Neonatal mice lacking functional Fas death receptors are resistant to hypoxic-ischemic brain injury. Neurobiol Dis 2004; 17: 89-98.
176. Fontaine RH, Cases O, Lelievre V, et al. IL-9/IL-9 receptor signaling selectively protects cortical neurons against developmental apoptosis. Cell Death Differ 2008; 15: 1542-1552.
177. Miller JT, Bartley JH, Wimborne HJ, et al. The neuroblast and angioblast chemotaxic factor SDF-1 (CXCL12) expression is briefly up regulated by reactive astrocytes in brain following neonatal hypoxic-ischemic injury. BMC Neurosci 2005; 6: 1-11.
178. Doverhag C, Hedtjarn M, Poirier F, et al. Galectin-3 contributes to neonatal hypoxic-ischemic brain injury. Neurobiol Dis 2010; 38: 36-46.
179. van den Tweel ER, Nijboer C, Kavelaars A, et al. Expression of nitric oxide synthase isoforms and nitrotyrosine formation after hypoxia-ischemia in the neonatal rat brain. J Neuroimmunol 2005; 167: 64-71.
180. Savman K, Blennow M, Gustafson K, et al. Cytokine response in cerebrospinal fluid after birth asphyxia. Pediatr Res 1998; 43: 746-751.